Abdurrahmaan Ali Suei Elbuzidi: What is the Optimal Anticoagulation Monitoring Target in ECMO?
Abdurrahmaan Ali Suei Elbuzidi, ECMO and Critical Care Consultant at Hamad Medical Corporation, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Cardiothoracic and Vascular Anesthesia, adding:
“Excited to share that our latest systematic review and meta-analysis has been published:
‘Clinical Outcomes of Different Heparin Anticoagulation Monitoring Targets in Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.’
This work explores an important and ongoing challenge in ECMO care:
What is the optimal anticoagulation monitoring target?
Despite widespread use of unfractionated heparin in ECMO, significant variability remains in monitoring strategies (ACT, aPTT, anti-Xa, and others), with potential implications for bleeding, thrombosis, and overall patient outcomes.
Our review aimed to synthesize the available evidence and evaluate how different monitoring targets may influence clinical outcomes.
Proud to have collaborated with an outstanding multidisciplinary team of colleagues on this project.Special thanks to all co-authors for their dedication and contributions.
Looking forward to continued research that helps refine anticoagulation strategies and improve outcomes for ECMO patients.”
Title: Clinical Outcomes of Different Heparin Anticoagulation Monitoring Targets in Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-analysis
Authors: Alaa Rahhal, Ans Alamami, Rabee Tawel, Ahmed Shebani, Hassan Fahed El Daezli, Abdurrahmaan Elbuzidi, Nadir Kharma, Amr Omar, Ahmed Labib Shehatta
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t